MYH9 Genetic Variants Associated With Glomerular Disease: What Is the Role for Genetic Testing?
To access this article, please choose from the options below
The National Institutes of Health, together with all three authors, has applied for a patent on MYH9 SNPs associated with the diseases described here.
This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400, and the Intramural Research Program of the National Institute for Diabetes, Digestive, and Kidney Diseases (ZO-1 DK043308). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, and mention of trade names, commercial products, or organizations does not imply endorsement by the US Government. The publisher or recipient acknowledges right of the US Government to retain a nonexclusive, royalty-free license in and to any copyright covering the article.
PII: S0270-9295(10)00099-9
doi:10.1016/j.semnephrol.2010.06.007
Published by Elsevier Inc.
